Advancements in drug manufacturing technologies are reshaping global regulatory frameworks. This shift is largely driven by the integration of artificial intelligence (AI)-powered models, cloud ...

Virtual and augmented reality tools have reached a level of maturity to be utilised across various industries. In this article, Ben Hargreaves asks whether there is particular potential for the ...

The government has disbursed Rs 14,020 crore under Production-Linked Incentive schemes for ten sectors, including electronics and pharma, since the launch of the support measure to boost domestic ...

Chris Rose of ProStrakan offers advice on selling in the pharmaceutical industry. The 80's and 90's spawned a host of selling models and most of us in the pharma business have been trained to use ...

Curium Pharma, a developer, manufacturer, and distributor of nuclear medicine, has acquired Eczacıbaşı-Monrol Nuclear Products Co. (Monrol), a nuclear medicine player headquartered in Istanbul, Turkey ...

The shooting of UnitedHealthcare CEO Brian Thompson in December rattled the industry and put healthcare CEOs in the spotlight in a way they were previously unaccustomed to. The months following ...

The contract will support R&D of high-quality APIs for substance use disorders and mental health conditions, starting with synthesis and scale-up of psilocybin, which is derived from mushrooms.

It isn’t easy to pin down the purpose of the Trump administration’s sweeping tariff agenda. Sometimes the president uses tariff threats to intimidate and gain leverage with trading partners.

Singota Solutions, a partner for pharmaceutical development and cGMP sterile drug product manufacturing as well as supply chain services, has opened a new facility in Balerna, Switzerland—bolstering ...